Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingo G H Schmidt-Wolf

Showing results (1-10 of 233) with videos related to

Pageof 24
Sort By:
Deutsche Medizinische Wochenschrift (1946)|April 30, 2015
[Gene therapy in Germany: from past to present]Young Kim, Ingo G H Schmidt-Wolf
Cellular & Molecular Immunology|May 10, 2023
Tempering of exhausted T cells to comprehend their adaptive response for suitable clinical translationAmit Sharma, Ingo G H Schmidt-Wolf
International Journal of Molecular Sciences|May 31, 2020
High Expression of Cannabinoid Receptor 2 on Cytokine-Induced Killer Cells and Multiple Myeloma CellsFrancesca Garofano, Ingo G H Schmidt-Wolf
Cancer Investigation|October 28, 2015
Prevalence, Supplementation, and Impact of Vitamin D Deficiency in Multiple Myeloma PatientsBeate Lauter, Ingo G H Schmidt-Wolf
German Medical Science : GMS E-Journal|August 25, 2011
Pulsing with blast cell lysate or blast-derived total RNA reverses the dendritic cell-mediated cytotoxic activity of cytokine-induced killer cells against allogeneic acute myelogenous leukemia cellsBjörn Schöttker, Ingo G H Schmidt-Wolf
Anticancer Research|October 3, 2014
Effect of Wnt inhibitors in pancreatic cancerIlona Wall, Ingo G H Schmidt-Wolf
Journal of Cellular Physiology|June 3, 2020
Ten-year update of the international registry on cytokine-induced killer cells in cancer immunotherapyYing Zhang, Ingo G H Schmidt-Wolf
Frontiers in Immunology|June 9, 2022
An Alternative Source for Allogeneic CAR T Cells With a High Safety ProfileXiaolong Wu, Ingo G H Schmidt-Wolf
Journal of Experimental & Clinical Cancer Research : CR|December 10, 2021
30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspectiveAmit Sharma, Ingo G H Schmidt-Wolf
Cancers|November 12, 2013
Natural killer T cells subsets in cancer, functional defects in prostate cancer and implications for immunotherapyMichael Nowak, Ingo G H Schmidt-Wolf
Pageof 24

Showing results (1-10 of 233) with videos related to

Sort By:
Pageof 24
Deutsche Medizinische Wochenschrift (1946)|April 30, 2015
[Gene therapy in Germany: from past to present]Young Kim, Ingo G H Schmidt-Wolf
Cellular & Molecular Immunology|May 10, 2023
Tempering of exhausted T cells to comprehend their adaptive response for suitable clinical translationAmit Sharma, Ingo G H Schmidt-Wolf
International Journal of Molecular Sciences|May 31, 2020
High Expression of Cannabinoid Receptor 2 on Cytokine-Induced Killer Cells and Multiple Myeloma CellsFrancesca Garofano, Ingo G H Schmidt-Wolf
Cancer Investigation|October 28, 2015
Prevalence, Supplementation, and Impact of Vitamin D Deficiency in Multiple Myeloma PatientsBeate Lauter, Ingo G H Schmidt-Wolf
German Medical Science : GMS E-Journal|August 25, 2011
Pulsing with blast cell lysate or blast-derived total RNA reverses the dendritic cell-mediated cytotoxic activity of cytokine-induced killer cells against allogeneic acute myelogenous leukemia cellsBjörn Schöttker, Ingo G H Schmidt-Wolf
Anticancer Research|October 3, 2014
Effect of Wnt inhibitors in pancreatic cancerIlona Wall, Ingo G H Schmidt-Wolf
Journal of Cellular Physiology|June 3, 2020
Ten-year update of the international registry on cytokine-induced killer cells in cancer immunotherapyYing Zhang, Ingo G H Schmidt-Wolf
Frontiers in Immunology|June 9, 2022
An Alternative Source for Allogeneic CAR T Cells With a High Safety ProfileXiaolong Wu, Ingo G H Schmidt-Wolf
Journal of Experimental & Clinical Cancer Research : CR|December 10, 2021
30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspectiveAmit Sharma, Ingo G H Schmidt-Wolf
Cancers|November 12, 2013
Natural killer T cells subsets in cancer, functional defects in prostate cancer and implications for immunotherapyMichael Nowak, Ingo G H Schmidt-Wolf
Pageof 24